Skip to main content
SpringerLink
Log in

PAF and LTB4 biosynthesis in the human neutrophil: Effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase

  • PLA2/5-Lipoxygenase
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The effect of several putative phospholipase A2 (PLA2) inhibitors on [3H]-acetate incorporation into platelet-activating factor (PAF) upon calcium ionophore A23187 stimulation of purified human neutrophils (PMN) were evaluatedin vitro. PLA2 inhibitors such asp-bromophenacyl bromide (pBPB), ellagic acid, aristolochic acid and gossypol were without effect or only weakly inhibited PAF biosynthesis. Luffariellolide, a potent PLA2 inhibitor isolated from the marine spongeLuffariella sp., dose-dependently inhibited PAF production (IC50=5 μM). Due to the relationship between PAF and LTB4 biosynthesis, the effect of inhibiting LTB4 production on PAF biosynthesis was investigated. At concentrations which reduce LTB4 production by >95%, Wy-50,295 tromethamine and A-64,077, specific 5-lipoxygenase (5-LO) inhibitors, did not significantly effect PAF production. In contrast, L-663,536, the 5-LO translocation inhibitor, was a potent inhibitor of PAF production (IC50=1 μM). This activity of L-663, 536 may contribute to its pharmacological profile at higher doses. These data also suggest that PAF biosynthesis in human PMNs is not dependent on the formation or continued presence of leukotrienes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J. Benveniste, M. Chignard, J. P. LeCouedic and B. B. Vargaftig,Biosynthesis of platelet-activation factor (PAF-Acether) II. Involvement of phospholipase A 2 in the formation of PAF-Acether and lyso-PAF-Acether from rabbit platelets. Thrombosis Res.25, 375–385 (1982).

    Article  Google Scholar 

  2. F. H. Chilton, J. M. Ellis, S. C. Olson and R. L. Wykle,1-0-Alkyl-2-arachidonyl-sn-glycero-3-phosphocholine: a common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J. Biol. Chem.259, 12014–12019 (1984).

    PubMed  Google Scholar 

  3. H. W. Mueller, J. T. O'Flaherty and R. L. Wykle,Biosynthesis of platelet-activating factor in rabbit polymorphonuclear neutrophils. J. Biol. Chem.258, 6213–6218 (1983).

    PubMed  Google Scholar 

  4. L. A. Marshall, A. Sung, R. Franson and J. Y. Chang,Pharmacological differences of phospholipase A2 purified from human synovial fluid of patients with rheumatoid arthritis and human platelets. FASEB J. 4, A1146 (1990).

    Google Scholar 

  5. K. F. Albizati, T. Hohlman, D. J. Faulkner, K. B. Glaser and R. S. Jacobs,Luffariellolide, an anti-inflammatory sesterterpene from the marine sponge Luffariella sp. Experientia43, 949–950 (1987).

    Article  Google Scholar 

  6. M. S. de Carvalho and R. S. Jacobs,Inhibition of eicosanoid release by scalaradial, a phospholipase A 2 inhibitor. The Pharamcologist32, 168 (1990).

    Google Scholar 

  7. M. F. Fitzgerald, L. Parente and B. J. R. Whittle,Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclooxygenase and lipoxygenase inhibition. Eur. J. Pharmacol.164, 539–546 (1989).

    Article  PubMed  Google Scholar 

  8. C. A. Rouzer, A. W. Ford-Hutchinson, H. E. Morton and J. W. Gillard,MK 886, a potent and specific leukotriene biosynthesis inhibitor block and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem.265, 1436–1442 (1990).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunopharmacology, Wyeth-Ayerst Research, CN 8000, 08543, Princeton, NJ, USA

    K. B. Glaser, Y. W. Lock & J. Y. Chang

Authors
  1. K. B. Glaser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. W. Lock
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Y. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glaser, K.B., Lock, Y.W. & Chang, J.Y. PAF and LTB4 biosynthesis in the human neutrophil: Effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase. Agents and Actions 34, 89–92 (1991). https://doi.org/10.1007/BF01993246

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01993246

Keywords

Search

Navigation